Originally posted by GenoMax
View Post
-
There must have been an issue with the original submission. The paper this data is based on states that all the runs were paired-end. -
--split-files option does not seem to be generating the correct files either for SRR639124.
Grab the fastq files from EBI: http://www.ebi.ac.uk/ena/data/view/SRR639124 hopefully they are correct over there.
Note: Even the EBI version has only 1 base in "paired" file.
At least it is consistent with the SRA record (that says 100 x 1): http://trace.ncbi.nlm.nih.gov/Traces/sra/?run=SRR639124@SRR639124.1 LEOPARD:627RGAAXX:4:001:00932:10203:0:1/2
N
+
B
It is useful to let SRA tech support know when you find records that do not seem to have the right downloads associated with them.Last edited by GenoMax; 01-20-2015, 09:49 AM.Comment
-
EBI may not have the right files either for all (here is an example: http://www.ebi.ac.uk/ena/data/view/SRR639239 says PAIRED but there is only one file).Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment